Niklas Zojer

Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization

Niklas Zojer, Robert Königsberg, Jutta Ackermann et al. · Blood · 2000 · 320 citations

Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose Chemotherapy

Johannes Drach, Jutta Ackermann, E. Fritz et al. · Blood · 1998 · 319 citations

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 231 citations · Full text

Regenerative Medicine, Cell Therapy, Transplantation +7

Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes

Johannes Drach, Andrea Gsur, G Hamilton et al. · Blood · 1996 · 223 citations · Full text

Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma

Heinz Ludwig, Roman Hájek, Elena Tóthová et al. · Blood · 2008 · 203 citations · Full text